Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 20

1.

Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe.

Matusewicz W, Godman B, Pedersen HB, Fürst J, Gulbinovič J, Mack A, Selke G, Timoney A, Warmińska E, Malmström RE.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):755-8. doi: 10.1586/14737167.2015.1085803. Epub 2015 Sep 14. No abstract available.

PMID:
26368060
2.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovič J, Jan S, Joppi R, Kalaba M, Magnisson E, McCullagh L, Miikkulainen K, Ofierska-Sujkowska G, Pedersen HB, Selke G, Sermet C, Spillane S, Supian A, Truter I, Vlahović-Palčevski V, Vien LE, Vural EH, Wale J, Władysiuk M, Zeng W, Gustafsson LL.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380. Review.

PMID:
25487078
3.

Quality indicators as a tool in improving the introduction of new medicines.

Campbell SM, Godman B, Diogene E, Fürst J, Gustafsson LL, MacBride-Stewart S, Malmström RE, Pedersen H, Selke G, Vlahović-Palčevski V, van Woerkom M, Wong-Rieger D, Wettermark B.

Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):146-57. doi: 10.1111/bcpt.12295. Epub 2014 Sep 19.

4.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. eCollection 2014. Review.

5.

A neuropsychological profile of childhood maltreatment within an adolescent inpatient sample.

Kavanaugh B, Holler K, Selke G.

Appl Neuropsychol Child. 2015;4(1):9-19. doi: 10.1080/21622965.2013.789964. Epub 2013 Oct 24.

PMID:
24156759
6.

Personalizing health care: feasibility and future implications.

Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL.

BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. Review.

7.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013.

8.

Improving the managed entry of new medicines: sharing experiences across Europe.

Godman B, Paterson K, Malmström RE, Selke G, Fagot JP, Mrak J.

Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):439-41. doi: 10.1586/erp.12.44.

PMID:
22971029
9.

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.

Godman B, Schwabe U, Selke G, Wettermark B.

Pharmacoeconomics. 2009;27(5):435-8. doi: 10.2165/00019053-200927050-00010. No abstract available.

PMID:
19586083
10.

The role of multidimensional attentional abilities in academic skills of children with ADHD.

Preston AS, Heaton SC, McCann SJ, Watson WD, Selke G.

J Learn Disabil. 2009 May-Jun;42(3):240-9. doi: 10.1177/0022219408331042. Epub 2009 Mar 5.

PMID:
19264927
11.

Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis.

Ufer M, Meyer SA, Junge O, Selke G, Volz HP, Hedderich J, Gleiter CH.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1153-60.

PMID:
17443868
12.

Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries.

De Ponti F, Poluzzi E, Vaccheri A, Bergman U, Bjerrum L, Ferguson J, Frenz KJ, McManus P, Schubert I, Selke G, Terzis-Vaslamatzis G, Montanaro N.

Br J Clin Pharmacol. 2002 Aug;54(2):171-7.

13.

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.

Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G.

Arch Gen Psychiatry. 2002 Apr;59(4):337-45. Review.

PMID:
11926934
14.

Glucose-induced increase in memory performance in patients with schizophrenia.

Newcomer JW, Craft S, Fucetola R, Moldin SO, Selke G, Paras L, Miller R.

Schizophr Bull. 1999;25(2):321-35.

15.

Decreased memory performance in healthy humans induced by stress-level cortisol treatment.

Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL.

Arch Gen Psychiatry. 1999 Jun;56(6):527-33.

PMID:
10359467
16.

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW.

Neuropsychopharmacology. 1999 Feb;20(2):106-18.

17.

Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans.

Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, Dagogo-Jack S.

Arch Gen Psychiatry. 1998 Nov;55(11):995-1000.

PMID:
9819068
18.

The German experience in reference pricing.

Giuliani G, Selke G, Garattini L.

Health Policy. 1998 Apr;44(1):73-85.

PMID:
10180203
19.

Robust leptin secretory responses to dexamethasone in obese subjects.

Dagogo-Jack S, Selke G, Melson AK, Newcomer JW.

J Clin Endocrinol Metab. 1997 Oct;82(10):3230-3.

PMID:
9329344
20.

Evolution of hospital financial data.

Selke G.

Osteopath Hosp Leadersh. 1986 Jun;30(4):16-8. No abstract available.

PMID:
10311633
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk